Nanoliter spectrophotometer maker to address DNA/RNA quantification, other apps

Oct. 24, 2008

OCTOBER 24, 2008 -- Trinean NV (Gentbrugge, Belgium), develops and markets what it calls "the first nanoliter spectrophotometer," has closed on 3.5 million Euro of financing. The funds will allow Trinean to start production, bring its products to market for nucleic acid concentration measurement, and develop applications such as ADME testing and protein quantitation.

OCTOBER 24, 2008 -- Trinean NV (Gentbrugge, Belgium), a spin-off of the University of Ghent (Intec) and the Belgium nanoelectronics research center IMEC, has closed on a 3.5 million Euro round of financing.

The company develops and markets what it calls "the first nanoliter spectrophotometer with corresponding micro fluidic consumables." Trinean says the product allows full spectrum UV/VIS spectroscopic measurements in droplets of liquids between 0.5 and 2.5 µL in a microplate format in a very fast and automated way.

The initial target application is nucleic acid quantitation -- that is, the determination of DNA/RNA concentrations in small sample volumes. "This is of great importance to the biotech industry where today valuable DNA/RNA material has to be sacrificed in order to measure these concentrations, and where test procedures are time consuming," the company says.

The investment round will allow Trinean to start production, bring its products to the market and develop new applications beyond DNA/RNA quantification, including ADME (absorption, distribution, metabolism, and excretion) testing, protein concentration measurements, enzymology, nephelometry, and clinical diagnostics.

More information:
Trinean NV